121 filings
Page 3 of 7
424B3
jpm6medl
11 Apr 23
Prospectus supplement
5:28pm
6-K
nzegxua81a5 jt9r
30 Mar 23
TC BioPharm Announces Pricing of $5.5 Million Public Offering
5:10pm
424B4
1daaphdkqsmlx
29 Mar 23
Prospectus supplement with pricing info
5:01pm
EFFECT
wv2tepuv2sjv0buqs1
28 Mar 23
Notice of effectiveness
12:15am
F-1/A
bp9tvje4z
27 Mar 23
Registration statement (foreign) (amended)
5:30pm
F-1
6ldfc xpiys13eos9
23 Mar 23
Registration statement (foreign)
5:27pm
CORRESP
6g3cuehssff25al5rwi
23 Mar 23
Correspondence with SEC
12:00am
UPLOAD
asvqjqsm4xynjbdm
16 Feb 23
Letter from SEC
12:00am
DRS
w46f811
10 Feb 23
Draft registration statement
12:00am
6-K
ntda4togtfa5br
19 Jan 23
Current report (foreign)
8:30am
6-K
vdl3po1q61qx 06b1
11 Jan 23
Current report (foreign)
1:49pm
424B3
ywckd6pcoymoj fzkaso
27 Dec 22
Prospectus supplement
4:05pm
EFFECT
1c9drs7
27 Dec 22
Notice of effectiveness
12:15am
CORRESP
yxwh04en1
21 Dec 22
Correspondence with SEC
12:00am
UPLOAD
bqkc0s4pbafns24suyr
16 Dec 22
Letter from SEC
12:00am
D
kvrv5h28d4lyl90
13 Dec 22
$7.35 mm in options / securities to be acquired, sold $7.35 mm, 2 investors
4:49pm
F-1
k6fech2ug0n2jls2h9q5
12 Dec 22
Registration statement (foreign)
4:02pm
6-K
1hpdsqn 9c9bl3g
12 Dec 22
Current report (foreign)
9:00am
6-K
ktby66qkm2sw x559w
30 Nov 22
Current report (foreign)
8:58am